Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-041033
Filing Date
2019-07-03
Accepted
2019-07-03 16:04:32
Documents
1
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7195
  Complete submission text file 0001209191-19-041033.txt   8699
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484
Business Address
Ives Jeffrey L. (Reporting) CIK: 0001614096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 19941927